1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GT BIOPHARMA INC

GT Biopharma Inc

XNAS: GTBP

Download real time

2.35 0.02 (0.86%)

77.95% Fall from 52W High

17,137 XNAS Volume

XNAS 04 Apr, 2025 4:00 PM (EDT)

Watchlist

Portfolio

Share
5S
5W
2O
0T
6

Market Cap

Low in industry
-0.5

PE TTM

Negative PE TTM
0

PEG TTM

-3.6

Price to Book

Negative Price to Book
-0.3

Beta 1Year

Very Low volatility


Insider Trading disclosures for GT Biopharma Inc

The latest disclosure was made by Alan Louis Urban in GT Biopharma Inc where a trade of 23,335 Option to purchase Common Stock done was reported to US exchanges on Oct. 17, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Alan Louis Urban Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 17 Oct 2024 23,335 23,335 - - Option to purchase Common Stock
Manu Ohri CFO & Secretary Other type of transaction at price $ 0.29 per share. 11 Aug 2023 200,000 300,000 - 0.3 57,400 Common Stock
Manu Ohri CFO & Secretary Other type of transaction at price $ 0.29 per share. 11 Aug 2023 200,000 0 - 0.3 57,400 Common Stock
Manu Ohri CFO & Secretary Grant, award, or other acquisition of securities at price $ 0.29 per share. 11 Aug 2023 200,000 200,000 - 0.3 57,400 Common Stock
Michael Breen Director, Executive Chairman/Interim CEO Grant, award, or other acquisition of securities at price $ 0.29 per share. 11 Aug 2023 200,000 856,218 - 0.3 57,400 Common Stock
Charles J. Casamento Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Jun 2023 500,000 500,000 - - Option to purchase Common Stock
Michael Breen Director, Executive Chairman/Interim CEO Purchase of securities on an exchange or from another person at price $ 0.50 per share. 11 Apr 2023 50,000 656,218 - 0.5 25,000 Common Stock
Manu Ohri CFO & Secretary Purchase of securities on an exchange or from another person at price $ 0.50 per share. 06 Apr 2023 50,000 50,000 - 0.5 25,000 Common Stock
Rajesh C. Shrotriya Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2023 500,000 500,000 - - Option to purchase Common Stock
Manu Ohri Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2023 500,000 500,000 - - Option to purchase Common Stock
Michael Breen Director, Exec Chairman and Interim CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2023 500,000 500,000 - - Option to purchase Common Stock
Bruce J. Wendel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 27 Jan 2023 500,000 500,000 - - Option to purchase Common Stock
Bruce J. Wendel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2022 50,000 50,000 - - Option to purchase Common Stock
Bruce J. Wendel Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2022 50,000 50,000 - - Option to purchase Common Stock
Rajesh C. Shrotriya Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2022 361,476 361,476 - - Option to purchase Common Stock
Rajesh C. Shrotriya Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2022 50,000 50,000 - - Option to purchase Common Stock
Rajesh C. Shrotriya Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2022 50,000 50,000 - - Option to purchase Common Stock
Manu Ohri CFO & Secretary Other type of transaction at price $ 0.00 per share. 15 Jul 2022 100,000 0 - 0 Common Stock
Manu Ohri CFO & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2022 100,000 100,000 - 0 Common Stock
Manu Ohri CFO & Secretary Other type of transaction at price $ 0.00 per share. 15 Jul 2022 100,000 100,000 - 0 Common Stock
Manu Ohri CFO & Secretary Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2022 200,000 200,000 - - Option to purchase Common Stock
Alan Louis Urban Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2022 50,000 50,000 - - Option to purchase Common Stock
Michael Breen Director, Exec. Chair. and Interim CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2022 50,000 50,000 - - Option to purchase Common Stock
Michael Breen Director, Exec. Chair. and Interim CEO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2022 278,058 606,218 - 0 Common Stock
Gregory I Berk Pres. of R&D, CMO Grant, award, or other acquisition of securities at price $ 0.00 per share. 15 Jul 2022 50,000 50,000 - - Option to purchase Common Stock
Michael Breen Director 16 Feb 2021 9,859 328,160 - 3.4 33,521 Common Stock
Michael Breen Director 16 Feb 2021 40,243 318,301 - 3.4 136,826 Common Stock
Michael Breen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2021 278,058 278,058 - 0 Common Stock
Michael Breen Director 16 Feb 2021 100,000 0 - - 10% Senior Convertible Debenture
Michael Breen Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 16 Feb 2021 50,000 50,000 - - Option to purchase Common Stock
Michael Breen Director 16 Feb 2021 30,000 0 - - 10% Senior Convertible Debenture
David Saloff Director, CEO, Chairman of the Board Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Mar 2012 26,334,193 27,650,684 - - Common Stock Option
David Saloff Director, Chief Executive Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 31 Aug 2011 538,713 1,316,491 - - Common Stock Option
Anshuman Dube Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Dec 2010 339,900 360,100 - - Common Stock
Anshuman Dube Director, Ten Percent Owner 23 Dec 2010 700,000 700,000 - - Common Stock
Anshuman Dube Director, Ten Percent Owner Sale of securities on an exchange or to another person at price $ 0.00 per share. 23 Dec 2010 360,100 0 - - Common Stock
Anshuman Dube Director, Ten Percent Owner 23 Dec 2010 700,000 1,100,000 - - 0% Convertible Debenture
Gary Post Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 31 Aug 2010 69,600 900,000 - - Common Stock
Gary Post Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Aug 2010 30,940 969,600 - - Common Stock
Gary Post Other Sale of securities on an exchange or to another person at price $ 0.00 per share. 26 Aug 2010 76,060 1,000,540 - - Common Stock
Gary Post Director, Secretary Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Jul 2010 50,000 1,076,600 - - Common Stock
Gary Post Director, Secretary Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Jul 2010 125,000 1,126,600 - - Common Stock
Gary Post Director, Secretary Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Jul 2010 35,000 1,251,600 - - Common Stock
Gary Post Director, Secretary Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Jul 2010 55,000 1,286,600 - - Common Stock
Gary Post Director, Secretary Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Jul 2010 33,400 1,341,600 - - Common Stock
Gary Post Director, Secretary Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Jul 2010 25,000 1,375,000 - - Common Stock
Gary Post Director, Secretary Sale of securities on an exchange or to another person at price $ 0.00 per share. 07 Jul 2010 100,000 1,400,000 - - Common Stock
Gary Post None 19 Jan 2010 100,000 429,583 - - Non-qualified Stock Option (right to buy)
Gary Post None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2010 1,110,227 1,539,810 - - Non-qualified Stock Option (right to buy)
Gary Post None Grant, award, or other acquisition of securities at price $ 0.00 per share. 19 Jan 2010 1,500,000 1,500,000 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters